Risk adjusted mortality after hip replacement surgery: a retrospective study
- PMID: 28361804
- DOI: 10.4415/ANN_17_01_09
Risk adjusted mortality after hip replacement surgery: a retrospective study
Abstract
Introduction: Hip replacement (HR) operations are increasing. Short term mortality is an indicator of quality; few studies include risk adjustment models to predict HR outcomes. We evaluated in-hospital and 30-day mortality in hospitalized patients for HR and compared the performance of two risk adjustment algorithms.
Materials and methods: A retrospective cohort study on hospital discharge records of patients undergoing HR from 2000 to 2005 in Tuscany Region, Italy, applied All-Patient Refined Diagnosis Related Groups (APR-DRG) and Elixhauser Index (EI) risk adjustment models to predict outcomes. Logistic regression was used to analyse the performance of the two models; C statistic (C) was used to define their discriminating ability.
Results: 25 850 hospital discharge records were studied. In-hospital and 30-day crude mortality were 1.3% and 3%, respectively. Female gender was a significant (p < 0.001) protective factor under both models and had the following Odds Ratios (OR): 0.64 for in-hospital and 0.51 for 30-day mortality using APR-DRG and 0.55 and 0.48, respectively, with EI. Among EI comorbidities, heart failure and liver disease were associated with in-hospital (OR 9.29 and 5.60; p < 0.001) and 30-day (OR 6.36 and 3.26; p < 0.001) mortality. Increasing age and APR-DRG risk class were predictive of all the outcomes. Discriminating ability for in-hospital and 30-day mortality was reasonable with EI (C 0.79 and 0.68) and good with APR-DRG (C 0.86 and 0.82).
Conclusions: Our study found that gender, age, EI comorbidities and APR-DRG risk of death are predictive factors of in-hospital and 30-day mortality outcomes in patients undergoing HR. At least one risk adjustment algorithm should always be implemented in patient management.
Similar articles
-
Short-term adjusted outcomes for heart failure.Heart Int. 2016 Feb 18;10(1):e1-5. doi: 10.5301/heartint.5000220. eCollection 2015 Jan-Dec. Heart Int. 2016. PMID: 27672431 Free PMC article.
-
Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients.J Bone Joint Surg Am. 2012 May 2;94(9):794-800. doi: 10.2106/JBJS.K.00072. J Bone Joint Surg Am. 2012. PMID: 22552668
-
[Quality of data or quality of care? Comparison of diverse standarization methods by clinical severity, based on the discharge form, in the analysis of hospital mortality].Epidemiol Prev. 1999 Oct-Dec;23(4):286-93. Epidemiol Prev. 1999. PMID: 10730469 Italian.
-
Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement.JAMA. 2015 Sep 15;314(11):1159-66. doi: 10.1001/jama.2015.10842. JAMA. 2015. PMID: 26372585
-
[Evaluation of the capacity of the APR-DRG classification system to predict hospital mortality].Epidemiol Prev. 2002 Jul-Aug;26(4):183-90. Epidemiol Prev. 2002. PMID: 12408005 Italian.
Cited by
-
Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty.Can J Surg. 2018 Jun;61(3):165-176. doi: 10.1503/cjs.007117. Can J Surg. 2018. PMID: 29806814 Free PMC article.
-
Epidemiology of Surgical Site Infections Considering the NHSN Standardized Infection Ratio in Hip and Knee Arthroplasties.Int J Environ Res Public Health. 2020 May 2;17(9):3167. doi: 10.3390/ijerph17093167. Int J Environ Res Public Health. 2020. PMID: 32370125 Free PMC article.
-
Comparison of Measures to Predict Mortality and Length of Stay in Hospitalized Patients.Nurs Res. 2019 May/Jun;68(3):200-209. doi: 10.1097/NNR.0000000000000350. Nurs Res. 2019. PMID: 30882561 Free PMC article.
-
The Update on Instruments Used for Evaluation of Comorbidities in Total Hip Arthroplasty.Indian J Orthop. 2021 Jan 26;55(4):823-838. doi: 10.1007/s43465-021-00357-x. eCollection 2021 Aug. Indian J Orthop. 2021. PMID: 34188772 Free PMC article. Review.
-
The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment.Medicina (Kaunas). 2022 Oct 28;58(11):1552. doi: 10.3390/medicina58111552. Medicina (Kaunas). 2022. PMID: 36363508 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous